Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00129376
Status:
COMPLETED
Last Update Posted:
2019-07-05
First Post:
2005-08-10
Brief Title:
Doxorubicin and Cyclophosphamide AC Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer Patients
Sponsor:
Organization:
Spanish Breast Cancer Research Group